Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis - Drugs.com MedNews
Links shared publicly online about this topic.
- 169total visits
Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis - Drugs.com MedNews
DR6 antagonist may play dual role in preventing axonal Jul 3, 2011 - Biogen Idec (NASDAQ BIIB), a leader in the research and development of treatments for peopl
View full resource at drugs.com
Tags: Multiple Sclerosis, Drug, Biogen Idec, Preventing
Most Recently Shared on July 5, 2011 at 2:01 pm By:
Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Acti... http://bit.ly/lGQaCY #drug
Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net
finanzen.net — “Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on July 3, 2011 at 9:56 pm By:
Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation... http://bit.ly/k3FOM9
Advertisement
